Cannabis law and policy continue to quickly evolve and the past year has seen major legal developments for the regulated marijuana and hemp industries. Moderated by Paul Demko, Cannabis Editor at POLITICO, this panel of experts bring their broad legal and policy perspectives to identify and comment upon important court rulings and litigation trends, as well as anticipated changes to the law heading into 2024 on a variety of legal topics.
In this session the panelists will discuss international hemp-derived products trade. More specifically, the panelists will offer an overview of what transatlantic trade of hemp-derived products (food products, cosmetic products, vaping products…) for consumer use looks like with a particular focus on import and export of these products from the US market to the EU and/or the UK market(s) and from the EU and/or the UK to the USA.
In this session the panelist will set the stage by discussing the Agricultural Improvement Act, more commonly known as the Farm Bill; specifically, the watershed moment in 2018 where industrial hemp was provided a federally legal pathway. The panel will discuss the unintended consequences created by the definition and function of weight allowance for delta-9 THC and its application to manufactured hemp derived products. The impacts of the definition on the hemp industry, the regulated marijuana industry and overall public health.
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
The panel will focus on the regulations applicable to foodstuff in the US, Mexico, Colombia and Chile. In particular, we will discuss different regulations in connection to dietary supplements, nutraceuticals, advertisement and further challenging issues for the industry, to later focus on the approach that these regulations have regarding the use of hemp in foodstuff products and future challenges in this regard.
The franchise business model offers hemp business owners the opportunity to grow their brand nationally while reducing their startup and operational costs. It offers prospective hemp franchisees the chance to own their own business while benefiting from an established brand and operational system. But a poorly created franchise system or an “accidental” franchise, can expose hemp businesses to the risk of regulatory investigation, litigation, and the loss of key IP such as trademarks and trade secrets. Conflicting state regulations and the lack of significant federal guidance makes franchising a hemp business even more complex.
Evolving cannabis product risks have the potential to result in enormous future liability for which cannabis and hemp companies are currently unprepared. This session will clarify those risks and discuss how embracing a mix of legal reform, policy changes and adoption of traditional risk management principles may prevent future product risk issues from damaging market sustainability.
To successfully navigate a government investigation of a licensed cannabis client, an attorney needs to assess which government agency (or agencies) is conducting the investigation, what are the potential outcomes, and what conflicts of interest may exist – all while taking in information in real time and often dealing with stressed clients. Any attorney may need to conduct an internal investigation at the same – and consider when to step aside and call in an expert. This panel will discuss responding to subpoenas, dealing with evolving disciplinary rules, respecting the Fourth and Fifth Amendment rights of individuals, and properly providing Upjohn warnings.